You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1

Not yet recruiting
  • HIV Vaccine
  • Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
  • +2 more
  • São Paulo, Brazil
    Hospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023

HIV I Infection Trial in United States (VIR-1388, Placebo)

Not yet recruiting
  • HIV I Infection
  • VIR-1388
  • Placebo
  • Birmingham, Alabama
  • +5 more
May 2, 2023

Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
  • (no location specified)
May 8, 2023

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

Human Immunodeficiency Virus (HIV), AIDS Virus Trial in Silver Spring (A244, B.63521, 50µg ALFQ)

Not yet recruiting
  • Human Immunodeficiency Virus (HIV)
  • AIDS Virus
  • A244
  • +4 more
  • Silver Spring, Maryland
    Walter Reed Army Institute of Research, Clinical Trials Center
Jul 20, 2022

HIV Trial in Bangkok (IHV01, A244, ALFQ)

Recruiting
  • HIV
  • IHV01
  • +3 more
  • Bangkok, Thailand
  • +1 more
Feb 15, 2022

Learn About The Effects Of Pneumococcal Vaccine In People With

Not yet recruiting
  • HIV
  • +2 more
  • Vaccine Administration
  • New York, New York
    Pfizer
Mar 20, 2023

Healthy Trial (763SIP8/MPLA-5 vaccine)

Not yet recruiting
  • Healthy
  • 763SIP8/MPLA-5 vaccine
  • (no location specified)
Mar 15, 2023

HIV Trial in Birmingham, Nashville, Seattle (Sub C gp140 Vaccine, MF59C.1 Adjuvant)

Completed
  • HIV Infections
  • Sub C gp140 Vaccine
  • MF59C.1 Adjuvant
  • Birmingham, Alabama
  • +2 more
Oct 13, 2021

Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)

Not yet recruiting
  • Vaccination; Infection
  • Vaccine Adverse Reaction
  • Recombinant zoster vaccination
  • (no location specified)
Jun 9, 2023

HIV Trial in Boston, Seattle, Nairobi (BG505 SOSIP.664 gp140, adjuvanted, Placebo)

Active, not recruiting
  • HIV Infections
  • BG505 SOSIP.664 gp140, adjuvanted
  • Placebo
  • Boston, Massachusetts
  • +2 more
May 6, 2022

HIV Trial (DNA-HIV-PT123 vaccine, NYVAC-HIV-PT1 vaccine, NYVAC-HIV-PT4 vaccine)

Withdrawn
  • HIV Infections
  • DNA-HIV-PT123 vaccine
  • +4 more
  • (no location specified)
Oct 13, 2021

HIV Trial in United States (PGT121.414.LS, VRC07-523LS)

Completed
  • HIV Infections
  • PGT121.414.LS
  • VRC07-523LS
  • Los Angeles, California
  • +4 more
Jan 31, 2023

HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)

Recruiting
  • HIV Vaccine
  • HIV-1-infection
  • C62
  • +4 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 27, 2022

HIV Trial (DNA Nat-B env vaccine, NYVAC Nat-B env vaccine, DNA CON-S env vaccine)

Withdrawn
  • HIV Infections
  • DNA Nat-B env vaccine
  • +7 more
  • (no location specified)
Oct 13, 2021

HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)

Active, not recruiting
  • HIV Infections
  • env (A,B,C,A/E)/gag (C) DNA Vaccine
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2022

Participants in Preventive HIV Vaccine Studies in Uganda

Completed
  • HIV Infections
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    HIV Trial in Kampala (VRC-HIVDNA009-00-VP, Placebo vaccine)

    Completed
    • HIV Infections
    • VRC-HIVDNA009-00-VP
    • Placebo vaccine
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

    Active, not recruiting
    • HIV-1-infection
    • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam University Medical Centers, location AMC
    Jan 31, 2023

    HIV, HIV Seronegativity Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452))

    Completed
    • HIV Infections
    • HIV Seronegativity
    • ALVAC(2)120(B,MN)GNP (vCP1452)
    • Birmingham, Alabama
    • +12 more
    Oct 13, 2021

    HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)

    Completed
    • HIV Infections
    • HIV Seronegativity
    • Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
    • +3 more
    • Baltimore, Maryland
      JHU AVEG
    Oct 27, 2021

    HIV Trial in Kampala (VRC-HIVADV014-00-VP Vaccine)

    Completed
    • HIV Infections
    • VRC-HIVADV014-00-VP Vaccine
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    HIV Trial in United States (VSV-Indiana HIV gag vaccine, Placebo injection (normal saline))

    Completed
    • HIV Infections
    • VSV-Indiana HIV gag vaccine
    • Placebo injection (normal saline)
    • San Francisco, California
    • +3 more
    Oct 13, 2021

    HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )

    Withdrawn
    • HIV Infections
    • VRC-HIVDNA016-00-VP
    • +3 more
    • (no location specified)
    Oct 28, 2021

    Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

    Completed
    • HIV Infections
    • +2 more
      • Baltimore, Maryland
      • +1 more
      Mar 17, 2023